Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

Original Article

J.H. Stone, M.J. Frigault, N.J. Serling-Boyd, A.D. Fernandes, L. Harvey, A.S. Foulkes, N.K. Horick, B.C. Healy, R. Shah, A.M. Bensaci, A.E. Woolley, S. Nikiforow, N. Lin, M. Sagar, H. Schrager, D.S. Huckins, M. Axelrod, M.D. Pincus, J. Fleisher, C.A. Sacks, M. Dougan, C.M. North, Y.-D. Halvorsen, T.K. Thurber, Z. Dagher, A. Scherer, R.S. Wallwork, A.Y. Kim, S. Schoenfeld, P. Sen, T.G. Neilan, C.A. Perugino, S.H. Unizony, D.S. Collier, M.A. Matza, J.M. Yinh, K.A. Bowman, E. Meyerowitz, A. Zafar, Z.D. Drobni, M.B. Bolster, M. Kohler, K.M. D’Silva, J. Dau, M.M. Lockwood, C. Cubbison, B.N. Weber, and M.K. Mansour

N Engl J Med 2020;383:2333-2344

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
12/09/2020
Course expires: 
12/10/2022

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation

Course closed

This course closed on Saturday, December 10, 2022 - 11:59pm.